Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
OPAT
elastomeric infusion devices
elastomers
meropenem
outpatient parenteral antimicrobial therapy
Journal
Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614
Informations de publication
Date de publication:
17 Jan 2024
17 Jan 2024
Historique:
medline:
17
1
2024
pubmed:
17
1
2024
entrez:
17
1
2024
Statut:
aheadofprint
Résumé
Although outpatient parenteral antibiotic therapy can be a good approach to treating infections, a lack of data regarding antibiotic stability in portable elastomeric infusion devices restricts its safe and effective use. Actually, meropenem is used for prolonged periods above 24 h, and it is not physicochemically stable, which can compromise efficacy and toxicity. This work is of high importance to show the clinicians the real shelf life of meropenem when administered in portable elastomeric infusion devices. We propose several administration protocols for meropenem in portable elastomeric infusion devices in clinical practice, according to the stability drug results obtained in our study.
Identifiants
pubmed: 38230930
doi: 10.1128/spectrum.02063-23
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM